Prolong Pharmaceuticals creates proprietary, high-value biopharmaceuticals utilizing a delivery system known as PEGylation. PEGylation is the only FDA-approved protein delivery technology that transforms proteins into superior drug products, by attaching a polyethylene glycol ("PEG") polymer to a therapeutic protein. This process, developed by the company's founder, results in an improved product with significantly enhance potency, fewer side effects, and a reduced dosing frequency.

What's New

Prolong Pharmaceuticals – PEGged For Success?

Oct. 1, 2008